381 related articles for article (PubMed ID: 33408339)
1. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
Tian J; Hong Y; Zhu Q; Zhou H; Zhang Y; Shen Z; Guo H; Zhang Y; Ai X; Zhao F; Rui K; Xu H; Wang S
Front Immunol; 2020; 11():604607. PubMed ID: 33414787
[TBL] [Abstract][Full Text] [Related]
3. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
4. Olfactory Ecto-mesenchymal Stem Cell-derived Exosomes Ameliorate Murine Sjögren's Syndrome via Suppressing Tfh Cell Response.
Rui K; Shen Z; Peng N; Zhao F; Tang Y; Liu S; Xu X; Liu C; Wu L; Tian J; Lu L
Rheumatol Immunol Res; 2022 Dec; 3(4):198-207. PubMed ID: 36879843
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
6. Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis
Tian J; Zhu Q; Zhang Y; Bian Q; Hong Y; Shen Z; Xu H; Rui K; Yin K; Wang S
Front Immunol; 2020; 11():598322. PubMed ID: 33362781
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndrome.
Wei Y; Peng N; Deng C; Zhao F; Tian J; Tang Y; Yu S; Chen Y; Xue Y; Xiao F; Zhou Y; Li X; Zou H; Rui K; Lin X; Lu L
Cell Mol Immunol; 2022 Dec; 19(12):1361-1372. PubMed ID: 36369368
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells exacerbate Sjögren's syndrome by inhibiting Th2 immune responses.
Qi J; Li D; Shi G; Zhang X; Pan Y; Dou H; Yao G; Hou Y
Mol Immunol; 2018 Sep; 101():251-258. PubMed ID: 30029059
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicle-encapsulated miR-10a-5p derived from MDSCs restrains germinal center B cells in experimental Sjögren's syndrome.
Zhou H; Zhu Q; Mao Z; Li M; Zhang Y; Yang J; Ma J; Tian J; Wang S
Immunol Res; 2023 Oct; 71(5):760-770. PubMed ID: 37300798
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
11. Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome.
Tian J; Rui K; Hong Y; Wang X; Xiao F; Lin X; Ma J; Guo H; Xu H; Ma K; Xu D; Liu D; Zhao Y; Lu L; Wang S
J Immunol; 2019 Mar; 202(6):1693-1703. PubMed ID: 30760623
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
[No Abstract] [Full Text] [Related]
13. Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells.
Xing Y; Li B; He J; Hua H
Front Immunol; 2022; 13():871096. PubMed ID: 35444638
[TBL] [Abstract][Full Text] [Related]
14. Dental pulp stem cell-derived exosomes revitalize salivary gland epithelial cell function in NOD mice via the GPER-mediated cAMP/PKA/CREB signaling pathway.
Hu S; Chen B; Zhou J; Liu F; Mao T; Pathak JL; Watanabe N; Li J
J Transl Med; 2023 Jun; 21(1):361. PubMed ID: 37268950
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome.
Xu J; Wang D; Liu D; Fan Z; Zhang H; Liu O; Ding G; Gao R; Zhang C; Ding Y; Bromberg JS; Chen W; Sun L; Wang S
Blood; 2012 Oct; 120(15):3142-51. PubMed ID: 22927248
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4
Ma D; Wu Z; Zhao X; Zhu X; An Q; Wang Y; Zhao J; Su Y; Yang B; Xu K; Zhang L
Inflammopharmacology; 2023 Aug; 31(4):1823-1838. PubMed ID: 37012581
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Zou Y; Xiao W; Liu D; Li X; Li L; Peng L; Xiong Y; Gan H; Ren X
Immun Inflamm Dis; 2024 Jan; 12(1):e1139. PubMed ID: 38270310
[TBL] [Abstract][Full Text] [Related]
19. SHED-derived exosomes ameliorate hyposalivation caused by Sjögren's syndrome via Akt/GSK-3β/Slug-mediated ZO-1 expression.
Du Z; Wei P; Jiang N; Wu L; Ding C; Yu G
Chin Med J (Engl); 2023 Nov; 136(21):2596-2608. PubMed ID: 37052137
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
